MaxVal and Aistemos Extend Litigation Data Partnership

Aistemos’s patent intelligence software, Cipher, now includes MaxVal’s international patent litigation data

Continue reading

Featured Patent Applications of the Week: March 28, 2019

Facebook seeks patent for surfacing employment opportunities on social media. Read about this and other recently published patent applications.

Continue reading

Medical Device Trends: Continued FDA focus on premarket pathways for innovation and safety

FDA’s Center for Devices and Radiological Health (CDRH)  approved a record-breaking 106 new medical devices in 2018. Medical devices approved by the FDA include Class I, Class II and Class III devices, categorized based on the potential risks involved in their use. Read all about it in this month's newsletter.

Continue reading

Featured Patents of the Week: March 26, 2019

In today's post, we look at Qualcomm, who has secured a patent for wireless charging of vehicles. Read about this and other recently published patents.

Continue reading

Featured Patent Applications of the Week: March 21, 2019

A new patent application hints at Facebook's plans to bring payment transactions into its messenger application. Read about it and other patent applications of the week in this post.

Continue reading

Featured Patents of the Week: March 19, 2019

Qualcomm has been awarded a patent for displays in autonomous vehicles. Learn about this and other recently published patents in today's post.

Continue reading

Featured Patent Applications of the Week: March 15, 2019

In this post, we take you through some of the recent patent applications filed by Facebook, Intel, Google, Qualcomm, Amazon, Apple, Medtronic, Novartis, Boston Scientific, Abbott, Merck, and Roche.

Continue reading

Featured Patents of the Week: March 13, 2019

In this post, we take you through some of the recent patents from Apple, Google, Qualcomm, Amazon, Intel, Facebook, Merck, Medtronic, Novartis, Pfizer, and Roche.  

Continue reading

Featured Patents and Applications of the Week: March 12, 2019

MaxVal’s new semiweekly column provides insights into recently issued patents and applications for some of the most innovative companies in the world.

Continue reading

Additional Patent Term Adjustment Potentially Available for Patents with IDS

Additional Patent Term Adjustment (PTA) may be available for some cases where an Information Disclosure Statement (IDS) was filed after a reply. Recently in Supernus Pharmaceuticals, Inc. v. Iancu, the U.S. Court of Appeals for the Federal Circuit held that the USPTO had incorrectly reduced the PTA based on applicant delay for a period of time during which there was no action that the applicant could take to conclude prosecution of the patent.

Continue reading